These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
732 related articles for article (PubMed ID: 9185968)
21. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours. Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066 [TBL] [Abstract][Full Text] [Related]
22. RITA/Registry of Industrial Toxicology Animal data: a comparative immunohistochemical study of 77 islet cell carcinomas in Sprague-Dawley and Wistar rats using antibodies against insulin, glucagon, somatostatin and gastrin. Germann PG; Heinrichs M; Püschner H; Hellmann J; Kohler M; Ernst H Exp Toxicol Pathol; 1999 Nov; 51(6):477-87. PubMed ID: 10661805 [TBL] [Abstract][Full Text] [Related]
23. Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study. Linder S; Myrvold K; Falkmer UG; Qvigstad G; Waldum HL; Falkmer SE J Exp Clin Cancer Res; 2006 Jun; 25(2):213-21. PubMed ID: 16918133 [TBL] [Abstract][Full Text] [Related]
24. Chromogranin A (CGA) in the gastro-entero-pancreatic (GEP) endocrine system. I. CGA in the mammalian endocrine pancreas. Grube D; Aunis D; Bader F; Cetin Y; Jörns A; Yoshie S Histochemistry; 1986; 85(6):441-52. PubMed ID: 2877960 [TBL] [Abstract][Full Text] [Related]
25. Measurement of plasma chromogranin A concentrations for assessment of stress responses in dogs with insulin-induced hypoglycemia. Akiyoshi H; Aoki M; Shimada T; Noda K; Kumagai D; Saleh N; Sugii S; Ohashi F Am J Vet Res; 2005 Oct; 66(10):1830-5. PubMed ID: 16273918 [TBL] [Abstract][Full Text] [Related]
26. Chromogranin A in the pancreatic islet: cellular and subcellular distribution. Ehrhart M; Grube D; Bader MF; Aunis D; Gratzl M J Histochem Cytochem; 1986 Dec; 34(12):1673-82. PubMed ID: 2878021 [TBL] [Abstract][Full Text] [Related]
27. Canine pancreatic endocrine tumors: immunohistochemical analysis of hormone content and amyloid. O'Brien TD; Hayden DW; O'Leary TP; Caywood DD; Johnson KH Vet Pathol; 1987 Jul; 24(4):308-14. PubMed ID: 2887054 [TBL] [Abstract][Full Text] [Related]
28. It's time to unamend the insulin-glucose ratio. Edwards DF J Am Vet Med Assoc; 1986 May; 188(9):951-3. PubMed ID: 3011720 [No Abstract] [Full Text] [Related]
29. [Usefulness of chromogranin A determination in the diagnosis of neuroendocrine neoplasia]. Militello C; Cannizzaro R; Pradella P; Volpin E; Spirch S; Buonadonna A; De Appollonia L; Rossi C; Sigon R; Cipresso S; Terranova O Chir Ital; 1999; 51(1):45-51. PubMed ID: 10514916 [TBL] [Abstract][Full Text] [Related]
30. Comparative study of endocrine cells in the principal pancreatic islets of two teleosts, Silurus asotus (Siluridae) and Siniperca scherzeri (Centropomidae). Lee JH; Ku SK; Park KD; Lee HS J Vet Sci; 2001 Aug; 2(2):75-80. PubMed ID: 14614274 [TBL] [Abstract][Full Text] [Related]
31. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors. Cussenot O; Villette JM; Cochand-Priollet B; Berthon P Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663 [TBL] [Abstract][Full Text] [Related]
32. Insulinoma in a cat. Greene SN; Bright RM J Small Anim Pract; 2008 Jan; 49(1):38-40. PubMed ID: 17784934 [TBL] [Abstract][Full Text] [Related]
33. Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin. Viale G; Doglioni C; Gambacorta M; Zamboni G; Coggi G; Bordi C Cancer; 1992 Nov; 70(9):2268-77. PubMed ID: 1356613 [TBL] [Abstract][Full Text] [Related]
34. Neuroendocrine differentiation in carcinomas of the prostate: do neuroendocrine serum markers reflect immunohistochemical findings? Angelsen A; Syversen U; Haugen OA; Stridsberg M; Mjølnerød OK; Waldum HL Prostate; 1997 Jan; 30(1):1-6. PubMed ID: 9018329 [TBL] [Abstract][Full Text] [Related]
35. Selective processing of chromogranin A in the different islet cells in human pancreas. Portela-Gomes GM; Stridsberg M J Histochem Cytochem; 2001 Apr; 49(4):483-90. PubMed ID: 11259451 [TBL] [Abstract][Full Text] [Related]
36. Chromogranin A as a biochemical marker for the management of neuroendocrine tumors: a multicenter study developed in Argentina. Belli SH; Oneto A; Aranda C; O'Connor JM; Domenichini E; Roca E; Méndez G; Bestani MC; Parma P; Giacomi N; Marmissolle F Acta Gastroenterol Latinoam; 2009 Sep; 39(3):184-9. PubMed ID: 19845257 [TBL] [Abstract][Full Text] [Related]
37. Comparison of plasma pancreastatin and GAWK concentrations, presumed processing products of chromogranin A and B, in plasma of patients with pancreatic islet cell tumors. Yasuda D; Iguchi H; Funakoshi A; Wakasugi H; Sekiya K; Misawa T; Tateishi K; Bloom SR; Nawata H Horm Metab Res; 1993 Nov; 25(11):593-5. PubMed ID: 8288164 [TBL] [Abstract][Full Text] [Related]
38. Resolution of superficial necrolytic dermatitis following excision of a glucagon-secreting pancreatic neoplasm in a dog. Torres SM; Caywood DD; O'Brien TD; O'Leary TP; McKeever PJ J Am Anim Hosp Assoc; 1997; 33(4):313-9. PubMed ID: 9204466 [TBL] [Abstract][Full Text] [Related]
39. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Gazdar AF; Helman LJ; Israel MA; Russell EK; Linnoila RI; Mulshine JL; Schuller HM; Park JG Cancer Res; 1988 Jul; 48(14):4078-82. PubMed ID: 3383200 [TBL] [Abstract][Full Text] [Related]